Journal of Clinical Medicine (Dec 2021)

Benefits of a Single Dose of Betamethasone in Imminent Preterm Labour

  • Natalia Saldaña-García,
  • María Gracia Espinosa-Fernández,
  • Celia Gómez-Robles,
  • Antonio Javier Postigo-Jiménez,
  • Nicholas Bello,
  • Francisca Rius-Díaz,
  • Tomás Sánchez-Tamayo

DOI
https://doi.org/10.3390/jcm11010020
Journal volume & issue
Vol. 11, no. 1
p. 20

Abstract

Read online

Background: A complete course of prenatal corticosteroids reduces the possibility of morbimortality and neonatal respiratory distress syndrome (RDS). Occasionally, it is not possible to initiate or complete the maturation regimen, and the preterm neonate is born in a non-tertiary hospital. This study aimed to assess the effects of a single dose of betamethasone within 3 h before delivery on serious outcomes (mortality and serious sequelae) and RDS in preterm neonates born in tertiary vs. non-tertiary hospitals. Materials and methods: Preterm neonates who were 2 (p = 0.01) was observed. Conclusions: A single dose of betamethasone up to 3 h antepartum may reduce the rate of serious outcomes and the severity of neonatal RDS, especially in non-tertiary hospitals.

Keywords